Therefore, to directly test whether a stiff stroma could drive the aggressiveness and metastatic behavior of human breast cancers, and to determine if this is linked to an EMT, we manipulated HER2+ human breast cancer patient-derived xenografts (PDX) in vivo. Here, ERBB2 is linked to breast carcinoma.